Amit M Oza Selected Research

Hand-Foot Syndrome

1/2020

Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amit M Oza Research Topics

Disease

102	Neoplasms (Cancer) 02/2024 - 01/2003
92	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 01/2002
25	Carcinoma (Carcinomatosis) 12/2023 - 04/2010
22	Ovarian Epithelial Carcinoma 01/2023 - 02/2007
20	Disease Progression 10/2023 - 01/2013
20	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 09/2005
12	Fatigue 10/2023 - 06/2008
11	Diarrhea 10/2023 - 07/2008
11	Neutropenia 01/2021 - 01/2010
9	Anemia 10/2023 - 06/2012
8	Hypertension (High Blood Pressure) 12/2021 - 01/2010
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 07/2010
7	Nausea 01/2020 - 06/2008
6	Asthenia 01/2021 - 01/2017
5	Thrombocytopenia (Thrombopenia) 10/2023 - 12/2016
5	Fallopian Tube Neoplasms 12/2021 - 07/2008
5	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2010
4	Proteinuria 12/2021 - 07/2014
4	Vomiting 01/2020 - 08/2017
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 07/2002
4	Adenocarcinoma 12/2019 - 07/2002
3	Lymphoma (Lymphomas) 10/2023 - 05/2009
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 11/2014
3	Hypoxia (Hypoxemia) 01/2016 - 06/2012
2	Microsatellite Instability 01/2022 - 12/2014
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 12/2014
2	Intestinal Obstruction (Obstruction, Intestinal) 01/2021 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 03/2005
2	Neoplasm Metastasis (Metastasis) 10/2017 - 01/2003
2	Abdominal Pain (Pain, Abdominal) 01/2017 - 07/2014
2	Ascites 10/2016 - 07/2014
2	Fistula 08/2015 - 01/2008
2	Carcinosarcoma 08/2014 - 04/2010
2	Hemorrhage 07/2014 - 01/2008
2	Mucositis 11/2013 - 10/2013

Drug/Important Bio-Agent (IBA)

52	PlatinumIBA 01/2023 - 08/2007
36	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2024 - 10/2013
21	rucaparibIBA 01/2023 - 01/2017
19	Biomarkers (Surrogate Marker)IBA 02/2024 - 04/2014
15	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2002
14	olaparibIBA 10/2023 - 10/2013
13	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2012
13	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 01/2016
12	Bevacizumab (Avastin)FDA Link 01/2024 - 01/2008
9	niraparibIBA 01/2023 - 12/2016
9	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 12/2011
7	adavosertibIBA 01/2023 - 12/2016
6	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2006
6	Gemcitabine FDA Link 11/2022 - 01/2006
5	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2020
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2009
5	Phosphotransferases (Kinase)IBA 01/2023 - 06/2012
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2008
4	AntigensIBA 02/2024 - 07/2009
4	Poly Adenosine Diphosphate RiboseIBA 01/2022 - 04/2017
4	TOR Serine-Threonine KinasesIBA 11/2015 - 10/2012
4	temsirolimus FDA Link 02/2014 - 08/2011
3	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 01/2019
3	Peptides (Polypeptides)IBA 12/2023 - 02/2012
3	binimetinibIBA 10/2023 - 12/2019
3	Circulating Tumor DNAIBA 01/2023 - 01/2019
3	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2019
3	Monoclonal AntibodiesIBA 01/2023 - 06/2008
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2017
3	Angiogenesis InhibitorsIBA 01/2021 - 12/2009
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2020 - 10/2012
3	veliparibIBA 01/2020 - 04/2015
3	trebananibIBA 10/2016 - 02/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2016 - 07/2008
3	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 04/2010
3	ridaforolimusIBA 11/2015 - 02/2014
3	MTOR InhibitorsIBA 11/2015 - 10/2012
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2015 - 10/2013
3	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 05/2015 - 10/2013
3	epothilone B (EPO906)IBA 04/2011 - 12/2005
2	Niacinamide (Nicotinamide)FDA LinkGeneric 05/2024 - 01/2023
2	cediranib (AZD2171)IBA 01/2023 - 01/2020
2	Folate Receptor 1IBA 01/2023 - 01/2019
2	CreatinineIBA 01/2023 - 01/2021
2	mirvetuximab soravtansineIBA 01/2023 - 01/2019
2	VaccinesIBA 08/2021 - 03/2011
2	avelumabIBA 01/2021 - 01/2021
2	TabletsIBA 01/2021 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 08/2017
2	Alanine Transaminase (SGPT)IBA 01/2021 - 08/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 12/2019
2	Hormones (Hormone)IBA 01/2020 - 09/2011
2	ENMD 2076IBA 12/2018 - 01/2013
2	ParaffinIBA 10/2016 - 05/2010
2	Angiopoietin-1IBA 10/2016 - 02/2012
2	Sunitinib (Sutent)FDA Link 11/2014 - 08/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 01/2008

Therapy/Procedure

70	Drug Therapy (Chemotherapy) 10/2023 - 07/2002
61	Therapeutics 02/2024 - 06/2003
5	Immunotherapy 12/2023 - 08/2015
5	Radiotherapy 01/2023 - 09/2005
4	Precision Medicine 12/2023 - 06/2016
3	Neoadjuvant Therapy 11/2023 - 01/2020
2	Palliative Care (Palliative Therapy) 06/2023 - 01/2021
2	Adjuvant Chemotherapy 01/2019 - 01/2019